Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.

Hugdahl E, Kalvenes MB, Puntervoll HE, Ladstein RG, Akslen LA.

Br J Cancer. 2016 Mar 29;114(7):801-8. doi: 10.1038/bjc.2016.44. Epub 2016 Feb 25.

2.

Frequencies of KIT and GNAQ mutations in acral melanoma.

Puntervoll HE, Molven A, Akslen LA.

J Cutan Pathol. 2014 Nov;41(11):893-4. doi: 10.1111/cup.12382. Epub 2014 Nov 3. No abstract available.

PMID:
25363280
3.

Frequency of somatic BRAF mutations in melanocytic lesions from patients in a CDK4 melanoma family.

Puntervoll HE, Molven A, Akslen LA.

Pigment Cell Melanoma Res. 2014 Jan;27(1):149-51. doi: 10.1111/pcmr.12191. Epub 2013 Nov 21. No abstract available.

PMID:
24256466
4.

Melanoma prone families with CDK4 germline mutation: phenotypic profile and associations with MC1R variants.

Puntervoll HE, Yang XR, Vetti HH, Bachmann IM, Avril MF, Benfodda M, Catricalà C, Dalle S, Duval-Modeste AB, Ghiorzo P, Grammatico P, Harland M, Hayward NK, Hu HH, Jouary T, Martin-Denavit T, Ozola A, Palmer JM, Pastorino L, Pjanova D, Soufir N, Steine SJ, Stratigos AJ, Thomas L, Tinat J, Tsao H, Veinalde R, Tucker MA, Bressac-de Paillerets B, Newton-Bishop JA, Goldstein AM, Akslen LA, Molven A.

J Med Genet. 2013 Apr;50(4):264-70. doi: 10.1136/jmedgenet-2012-101455. Epub 2013 Feb 5. Erratum in: J Med Genet. 2014 Mar;51(3):214.

5.

Loss of BMI-1 expression is associated with clinical progress of malignant melanoma.

Bachmann IM, Puntervoll HE, Otte AP, Akslen LA.

Mod Pathol. 2008 May;21(5):583-90. doi: 10.1038/modpathol.2008.17. Epub 2008 Feb 8.

6.

Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.

Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA.

Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8606-14.

Supplemental Content

Loading ...
Support Center